Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Manikay Master Fund, LP et al v. Akorn, Inc. et al
Case Number:
1:19-cv-04651
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
October 01, 2020
Akorn Seeks Del. Ch. 11 OK For $9M Stockholder Suit Deal
Bankrupt biopharmaceutical company Akorn Inc. sought a Delaware court's approval late Wednesday for an at least $9 million global settlement of holdout-stockholder suits targeting the company for regulatory and data integrity failures that collapsed its $4.3 billion merger agreement with Fresenius Kabi AG in 2017.
-
February 06, 2020
Akorn Can't Duck Investor Suits Over Collapsed $4.3B Merger
Akorn Inc. must face two securities fraud suits over its $4.3 billion merger that imploded after regulatory violations came to light, an Illinois federal judge ruled Wednesday, finding that the generic drug-maker plausibly deceived shareholders in its financial filings.